Conmed announced that it plans to exit its gastroenterology product lines as part of a broader portfolio optimization ...

Medical device company and surgical equipment manufacturer ConMed plans to exit its gastroenterology product lines.  ConMed’s gastroenterology segment is projected to generate about $90 million in ...

The medical-technology company on Friday said this exit allows it to align operations and resources within its core markets: minimally invasive, robotic, and laparoscopic surgery, smoke evacuation, ...

CONMED Corporation CNMD reported weaker-than-expected fourth-quarter financial results on Wednesday. Conmed posted adjusted earnings of $1.06 per shares, missing market estimates of $1.11 per share.

Surgical devices and technology provider Conmed Corporation (CNMD) recently announced plans to co-develop a sequence of educational programs along with Exactech, Inc. (EXAC). Exactech provides ...

The latest price target for Conmed (NYSE:CNMD) was reported by Stifel on February 6, 2025. The analyst firm set a price target for $75.00 expecting CNMD to rise to within 12 months (a possible 54.35% ...